Skip to main content

Advertisement

SpringerLink
Log in

Volatile Substance Misuse: An Updated Review of Toxicity and Treatment

  • Published:
Clinical Reviews in Allergy & Immunology Aims and scope Submit manuscript

Abstract

Educational campaigns and legislative actions may have led to an overall decrease in the prevalence of volatile substance misuse (VSM) in many countries; however, it is still a common practice throughout the world. Studies currently suggest that girls are misusing volatile substances more than before and at a prevalence rate equal to or exceeding that of boys in several countries. Products that may be misused are ubiquitous and relatively easy to acquire. The most commonly misused substances in recent studies are fuels such as butane or petrol and compressed gas dusters and deodorants that may contain fluorocarbons and/or butane. Detection of VSM is challenging, therefore physicians must maintain a high level of suspicion based on history and clinical presentation. Clues to misuse are often subtle and may include the patient's proximity to a volatile substance or paraphernalia when found intoxicated, dermal burns, blisters, pigments, or rashes, and chemical odors. The primary targets of toxicity are the brain and the heart. The leading cause of death from VSM is from ventricular dysrhythmias. Treatment of toxicity begins with support of airway, breathing, and circulation. Exogenous catecholamines should be avoided if possible due to the theoretical “sensitized” and irritable myocardium. In the case of ventricular dysrhythmias, direct current defibrillation and/or beta-adrenergic receptor antagonism should be used. New evidence demonstrates the addictive potential of VSM yet effective therapy remains uncertain. Further research is needed in developing methods for preventing, detecting, and treating the harmful effects of VSM.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Marelich GP (1997) Volatile substance abuse. Clin Rev Allergy Immunol 15:271–289

    CAS  PubMed  Google Scholar 

  2. Johnston LD, O”Malley PM, Bachman JG, Schulenberg JE (2012) Table 2 Trends in Annual Prevalence of Use of Various Drugs in Grades 8, 10, and 12. The Monitoring the Future study, the University of Michigan. Retrieved February 12, 2013 from http://www.monitoringthefuture.org

  3. Hibell B, Andersson B, Bjarnason T, Kokkevi A, Morgan M, Narusk A (1995) The 1995 ESPAD Report Alcohol and Other Drug Use Among Student in 26 European Countries. Retrieved February 12, 2013 from http://www.espad.org/en/Reports--Documents/ESPAD-Reports/

  4. Hibell B, Guttormsson U, Ahlström S et al. (2007) The 2007 ESPAD Report Substance Use Among Students in 35 European Countries. Retrieved February 12, 2013 from http://www.espad.org/en/Reports--Documents/ESPAD-Reports

  5. Hibell B, Guttormsson U, Ahlström S et al. (2011) The 2011 ESPAD Report Substance Use Among Students in 36 European Countries. Retrieved February 12, 2013 from http://www.espad.org/en/Reports--Documents/ESPAD-Reports

  6. Villatoro JA, Cruz SL, Ortiz A, Medina-Mora ME (2011) Volatile substance misuse in Mexico: correlates and trends. Subst Use Misuse 46(Suppl 1):40–45

    PubMed  Google Scholar 

  7. Neumark Y, Bar-Hamburger R (2011) Volatile substance misuse among youth in Israel: results of a national school survey. Subst Use Misuse 46(Suppl 1):21–26

    PubMed  Google Scholar 

  8. White V, Smith G (2009) Tobacco, alcohol, over-the-counter and illicit substance use among Australian secondary school students 2008, Report prepared for: Drug Strategy Branch Australian Government Department of Health and Ageing. Retrieved February 12, 2013 from http://www.decd.sa.gov.au/drugstrategy/files/links/ASSADS_Aust_sec_schools_re.pdf

  9. Johnston L, O”Malley PM, Bachman JG, Schulenberg JE (2012) Monitoring the Future national survey results on drug use, 1975–2011. Volume I: Secondary school students. Ann Arbor: Institue for Social Research, The University of Michigan. Retrieved February 12, 2013 from http://www.monitoringthefuture.org/pubs.html

  10. Butland BK, Field-Smith ME, Ramsey JD, Anderson HR (2012) Twenty-five years of volatile substance abuse mortality: a national mortality surveillance programme. Addiction 108:385–393

    PubMed  Google Scholar 

  11. Spiller H, Lorenz DJ (2009) Trends in volatile substance abuse. J Addict Dis 28:164–170

    PubMed  Google Scholar 

  12. Dell D, Hopkins C (2011) Residential volatile substance misuse treatment for indigenous youth in Canada. Substance Use & Misuse 46:107–113

    Google Scholar 

  13. Wallace EA, Green AS (2009) Methanol toxicity secondary to inhalant abuse in adult men. Clin Toxicol 47:239–242

    Google Scholar 

  14. LoVecchio F, Sawyers B, Thole D, Beuler MC, Winchell J, Curry SC (2004) Outcomes following abuse of methanol-containing carburetor cleaners. Hum Exp Toxicol 23:473–475

    CAS  PubMed  Google Scholar 

  15. Bronstein AC, Spyker DA, Cantilena LR Jr, Rumack BH, Dart RC (2012) 2011 Annual Report of the American Association of Poison Control Centers’ National Poison Data System (NPDS): 29th Annual Report. Clin Toxicol 50:911–1164

    Google Scholar 

  16. Marsolek MR, White NC, Litovitz TL (2010) Inhalant abuse: monitoring trends by using poison control data, 1993–2008. Pediatrics 125:906–913

    PubMed  Google Scholar 

  17. Avella J, Kunaparaju N, Kumar S, Lehrer M, Zito SW, Barletta M (2010) Uptake and distribution of the abused inhalant 1,1-difluoroethane in the rat. J Anal Toxicol 34:381–388

    CAS  PubMed  Google Scholar 

  18. Pegg DG, Zempel JA, Braun WH, Watanabe PG (1979) Disposition of tetrachloro(14C)ethylene following oral and inhalation exposure in rats. Toxicol Appl Pharmacol 51:465–474

    CAS  PubMed  Google Scholar 

  19. Omar SA, Artime E, Webb AJ (2012) A comparison of organic and inorganic nitrates/nitrites. Nitric Oxide: Biol Chem 26:229–240

    CAS  Google Scholar 

  20. Löf A, Wigaeus Hjelm E, Colmsjö A, Lundmark BO, Norström A, Sato A (1993) Toxicokinetics of toluene and urinary excretion of hippuric acid after human exposure to 2H8-toluene. Br J Ind Med 50:55–59

    PubMed Central  PubMed  Google Scholar 

  21. Tsukamoto S, Chiba S, Muto T, Ishikawa T, Shimamura M (1985) Study on the metabolism of volatile hydrocarbons in mice—propane, n-butane, and iso-butane. J Toxicol Sci 10:323–332

    CAS  PubMed  Google Scholar 

  22. Needleman P (1976) Organic nitrate metabolism. Annu Rev Pharmacol Toxicol 16:81–93

    CAS  PubMed  Google Scholar 

  23. Wennmalm A, Benthin G, Edlund A et al (1993) Metabolism and excretion of nitric oxide in humans. An experimental and clinical study. Circ Res 73:1121–1127

    CAS  PubMed  Google Scholar 

  24. Spigel S (2009) State Laws on Inhalent use, Office of Legislation Research Report. Retrieved February 12, 2013 from http://www.cga.ct.gov/2009/rpt/2009-R-0251.htm

  25. Drug & Alcohol Information Centre (2007) Volatile Substance Misuse Drug and Alcohol Information Centre. Retrieved February 7, 2013 from http://www.drugarm.com.au/files/pdf/VSM.PDF

  26. MacLean SJ, D”abbs PH (2011) Five challenges for volatile substance misuse policy and intervention in Australia. Drug Alcohol Rev 30:223–227

    PubMed  Google Scholar 

  27. Bowen SE, Batis JC, Paez-Martinez N, Cruz SL (2006) The last decade of solvent research in animal models of abuse: mechanistic and behavioral studies. Neurotoxicol Teratol 28:636–647

    CAS  PubMed  Google Scholar 

  28. Cruz SL, Gauthereau MY, Camacho-Munoz C, Lopez-Rubalcava C, Balster RL (2003) Effects of inhaled toluene and 1,1,1-trichloroethane on seizures and death produced by N-methyl-d-aspartic acid in mice. Behav Brain Res 140:195–202

    CAS  PubMed  Google Scholar 

  29. Lopreato GF, Phelan R, Borghese CM, Beckstead MJ, Mihic SJ (2003) Inhaled drugs of abuse enhance serotonin-3 receptor function. Drug Alcohol Depend 70:11–15

    CAS  PubMed  Google Scholar 

  30. Beckstead MJ, Weiner JL, Eger EI 2nd, Gong DH, Mihic SJ (2000) Glycine and gamma-aminobutyric acid(A) receptor function is enhanced by inhaled drugs of abuse. Mol Pharmacol 57:1199–1205

    CAS  PubMed  Google Scholar 

  31. Stengard K, Hoglund G, Ungerstedt U (1994) Extracellular dopamine levels within the striatum increase during inhalation exposure to toluene: a microdialysis study in awake, freely moving rats. Toxicol Lett 71:245–255

    CAS  PubMed  Google Scholar 

  32. Gerasimov MR, Schiffer WK, Marstellar D, Ferrieri R, Alexoff D, Dewey SL (2002) Toluene inhalation produces regionally specific changes in extracellular dopamine. Drug Alcohol Depend 65:243–251

    CAS  PubMed  Google Scholar 

  33. Riegel AC, Zapata A, Shippenberg TS, French ED (2007) The abused inhalant toluene increases dopamine release in the nucleus accumbens by directly stimulating ventral tegmental area neurons. Neuropsychopharmacology 32:1558–1569

    CAS  PubMed  Google Scholar 

  34. Funada M, Sato M, Zhou X, Kanai H, Wada K (2005) Neuroadaptive mechanisms form development of psychological dependence on volatile organic solvents. Japan J Psychopharm 25:1–9

    CAS  Google Scholar 

  35. Perron BE, Howard MO, Vaughn MG, Jarman CN (2009) Inhalant withdrawal as a clinically significant feature of inhalant dependence disorder. Med Hypotheses 73:935–937

    PubMed Central  PubMed  Google Scholar 

  36. Kouzoupis AV, Konstantakopoulos G, Oulis P, Kalfakis N, Papageorgiou SG (2010) A case of severe toluene withdrawal syndrome treated with clonazepam. J Neuropsychiatr Clin Neurosci 22:E16–E17

    Google Scholar 

  37. Papageorgiou SG, Karantoni E, Pandis D, Kouzoupis AV, Kalfakis N, Limouris GS (2009) Severe dopaminergic pathways damage in a case of chronic toluene abuse. Clin Neurol Neurosurg 11:864–867

    Google Scholar 

  38. Grosse K, Grosse J (2000) Propane abuse. Extreme dose increase due to development of tolerance. Der Nervenarzt 71:50–53

    CAS  PubMed  Google Scholar 

  39. Cruz SL, Dominguez M (2011) Misusing volatile substances for their hallucinatory effects: a qualitative pilot study with Mexican teenagers and a pharmacological discussion of their hallucinations. Subst Use Misuse 46(Suppl 1):84–94

    PubMed  Google Scholar 

  40. Broussard LA, Brustowicz T, Pittman T, Atkins KD, Presley L (1997) Two traffic fatalities related to the use of difluoroethane. J Forensic Sci 42:1186–1187

    CAS  PubMed  Google Scholar 

  41. Hahn T, Avella J, Lehrer M (2006) A motor vehicle accident fatality involving the inhalation of 1,1-difluoroethane. J Anal Toxicol 30:638–642

    CAS  PubMed  Google Scholar 

  42. Fitzgerald RL, Fishel CE, Bush LL (1993) Fatality due to recreational use of chlorodifluoromethane and chloropentafluoroethane. J Forensic Sci 38:477–483

    CAS  PubMed  Google Scholar 

  43. Turkoglu C, Aliyev F, Celiker C, Uzunhasan I, Kocas C (2010) Slow heart-slow brain: consequence of short-term occupational exposure to toluene in a young woman: what is the real mechanism? Clin Cardiol 33:E68–E71

    PubMed  Google Scholar 

  44. Sterman AB, Coyle PK (1983) Subacute toxic delirium following nitrous oxide abuse. Arch Neurol 40:446–447

    CAS  PubMed  Google Scholar 

  45. Harris D, Mirza Z (2005) Butane encephalopathy. Emerg Med J 22:676–677

    CAS  PubMed  Google Scholar 

  46. Kile SJ, Camilleri CC, Latchaw RE, Tharp BR (2006) Bithalamic lesions of butane encephalopathy. Pediatr Neurol 35:439–441

    PubMed  Google Scholar 

  47. Doring G, Baumeister FA, Peters J, von der Beek J (2002) Butane abuse associated encephalopathy. Klinische Padiatr 214:295–298

    CAS  Google Scholar 

  48. Feuillet L, Mallet S, Spadari M (2006) Twin girls with neurocutaneous symptoms caused by mothball intoxication. N Engl J Med 355:423–424

    CAS  PubMed  Google Scholar 

  49. Kumar N, Dale LC, Wijdicks EF (2009) Mothball mayhem: relapsing toxic leukoencephalopathy due to p-dichlorobenzene neurotoxicity. Ann Intern Med 150:362–363

    PubMed  Google Scholar 

  50. Reygagne A, Garnier R, Chataigner D, Echenne B, Efthymiou ML (1992) Encephalopathy due to repeated voluntary inhalation of paradichlorobenzene. Journal De Toxicologie Clinique Et Experimentale 12:247–250

    CAS  PubMed  Google Scholar 

  51. Hernandez SH, Wiener SW, Smith SW (2010) Case files of the New York City poison control center: paradichlorobenzene-induced leukoencephalopathy. J Med Toxicol 6:217–229

    PubMed Central  PubMed  Google Scholar 

  52. Peyravi M, Mirzayan MJ, Krauss JK (2012) Fatal outcome despite bilateral decompressive craniectomy for refractory intracranial pressure increase in butane intoxication. Clin Neurol Neurosurg 114:392–393

    PubMed  Google Scholar 

  53. D”Costa DF, Gunasekera NP (1990) Fatal cerebral oedema following trichloroethane abuse. J Royal Soc Med 83:533–534

    Google Scholar 

  54. Mutez E, Le Rhun E, Perriol MP et al (2006) Trichloroethylene intoxication presenting with temporal seizures. Rev Neurol 162:1248–1251

    CAS  PubMed  Google Scholar 

  55. Rutchik JS, Wittman RI (2004) Neurologic issues with solvents. Clinics in occupational and environmental medicine 4:621–56

    Google Scholar 

  56. Rosenberg NL, Grigsby J, Dreisbach J, Busenbark D, Grigsby P (2002) Neuropsychologic impairment and MRI abnormalities associated with chronic solvent abuse. J Toxicol Clin Toxicol 40:21–34

    PubMed  Google Scholar 

  57. Takagi M, Yucel M, Cotton SM et al (2011) Verbal memory, learning, and executive functioning among adolescent inhalant and cannabis users. J Stud Alcohol drugs 72:96–105

    PubMed  Google Scholar 

  58. Dingwall KM, Cairney S (2011) Recovery from central nervous system changes following volatile substance misuse. Subst Use Misuse 46:73–83

    PubMed  Google Scholar 

  59. Cairney S, Maruff P, Burns CB, Currie J, Currie BJ (2005) Neurological and cognitive recovery following abstinence from petrol sniffing. Neuropsychopharmacology 30:1019–1027

    PubMed  Google Scholar 

  60. Hormes JT, Filley CM, Rosenberg NL (1986) Neurologic sequelae of chronic solvent vapor abuse. Neurology 36:698–702

    CAS  PubMed  Google Scholar 

  61. Lloyd MJ, Fraunfelder FW (2007) Drug-induced optic neuropathies. Drugs Today 43:827–836

    CAS  PubMed  Google Scholar 

  62. Twardowschy CA, Teive HA, Siquineli F et al (2008) Optic neuritis due to solvent abuse. Arquivos de neuro-psiquiatria 66:108–110

    PubMed  Google Scholar 

  63. Tamrazi B, Almast J (2012) Your brain on drugs: imaging of drug-related changes in the central nervous system. Radiographics 32:701–719

    PubMed  Google Scholar 

  64. Borne J, Riascos R, Cuellar H, Vargas D, Rojas R (2005) Neuroimaging in drug and substance abuse part II: opioids and solvents. Top Magn Reson Imaging 16:239–245

    PubMed  Google Scholar 

  65. Hashizume A, Koike H, Kawagashira Y et al (2011) Central nervous system involvement in n-hexane polyneuropathy demonstrated by MRI and proton MR spectroscopy. Clin Neurol Neurosurg 113:493–495

    CAS  PubMed  Google Scholar 

  66. Robinson RO (1978) Tetraethyl lead poisoning from gasoline sniffing. JAMA 240:1373–1374

    CAS  PubMed  Google Scholar 

  67. Boeckx RL, Postl B, Coodin FJ (1978) Gasoline sniffing and tetraethyl lead poisoning in children. Pediatrics 60:140–145

    Google Scholar 

  68. Goodheart RS, Dunne JW (1994) Petrol sniffer’s encephalopathy. A study of 25 patients. Med J Aust 160:178–181

    CAS  PubMed  Google Scholar 

  69. Ross CA (1982) Gasoline sniffing and lead encephalopathy. Can Med Assoc J 127:1195–1197

    CAS  PubMed Central  PubMed  Google Scholar 

  70. Clune AL, Falk H, Riederer AM (2011) Mapping Global Environmental Lead Poisoning in Children. Journal of Health and Pollution. 1. Retrieved on February 13, 2013 from http://www.journalhealthpollution.org/ojs/ojs2.2.4/index.php/journalhealthpollution/article/view/43/64.

  71. Tenenbein M (1997) Leaded gasoline abuse: the role of tetraethyl lead. Hum Exp Toxicol 16:217–222

    CAS  PubMed  Google Scholar 

  72. King GS, Smialek JE, Troutman WG (1985) Sudden death in adolescents resulting from the inhalation of typewriter correction fluid. JAMA 253:1604–1606

    CAS  PubMed  Google Scholar 

  73. Smeeton WM, Clark MS (1985) Sudden death resulting from inhalation of fire extinguishers containing bromochlorodifluoromethane. Med Sci Law 25:258–262

    CAS  PubMed  Google Scholar 

  74. Brady WJ Jr, Stremski E, Eljaiek L, Aufderheide TP (1994) Freon inhalational abuse presenting with ventricular fibrillation. Am J Emerg Med 12:533–536

    PubMed  Google Scholar 

  75. Rohrig TP (1997) Sudden death due to butane inhalation. The Am J Forensic Med Pathol 18:299–302

    CAS  Google Scholar 

  76. Williams DR, Cole SJ (1998) Ventricular fibrillation following butane gas inhalation. Resuscitation 37:43–45

    CAS  PubMed  Google Scholar 

  77. Sugie H, Sasaki C, Hashimoto C et al (2004) Three cases of sudden death due to butane or propane gas inhalation: analysis of tissues for gas components. Forensic Sci Int 143:211–214

    CAS  PubMed  Google Scholar 

  78. Rieder-Scharinger J, Peer R, Rabl W, Hasibeder W, Schobersberger W (2000) Multiple organ failure following inhalation of butane gas: a case report. Wien Klin Wochenschr 112:1049–1052

    CAS  PubMed  Google Scholar 

  79. LoVecchio F, Fulton SE (2001) Ventricular fibrillation following inhalation of Glade Air Freshener. Eur J Emerg Med 8:153–154

    CAS  PubMed  Google Scholar 

  80. Girard F, Le Tacon S, Maria M, Pierrard O, Monin P (2008) Ventricular fibrillation following deodorant spray inhalation. Annales francaises d”anesthesie et de reanimation 27:83–85

    CAS  Google Scholar 

  81. Godlewski K, Werner B, Sterlinski M et al (2006) Myocardial infarction after butane inhalation in a 14-year-old boy. Kardiologia polska 64:305–308

    PubMed  Google Scholar 

  82. De Naeyer AH, de Kort SW, Portegies MC, Deraedt DJ, Buysse CM (2011) Myocardial infarction in a 16-year old following inhalation of butane gas. Ned Tijdschr Geneeskd 155:A3443

    PubMed  Google Scholar 

  83. Edwards KE, Wenstone R (2000) Successful resuscitation from recurrent ventricular fibrillation secondary to butane inhalation. Br J Anaesth 84:803–805

    CAS  PubMed  Google Scholar 

  84. Woods DT, Perry AW, Solomou S (2012) The neuropsychological sequelae of a 14-year-old girl following successful resuscitation from ventricular fibrillation and collapse secondary to butane gas inhalation. Resuscitation 83:e214–e215

    PubMed  Google Scholar 

  85. Dodd DE, Vinegar A (1998) Cardiac sensitization testing of the halon replacement candidates trifluoroiodomethane (CF3I) and 1,1,2,2,3,3,3-heptafluoro-1-iodopropane (C3F7I). Drug Chem Toxicol 21:137–149

    CAS  PubMed  Google Scholar 

  86. Reinhardt CF, Mullin LS, Maxfield ME (1973) Epinephrine-induced cardiac arrhythmia potential of some common industrial solvents. J Occup Med 15:953–955

    CAS  PubMed  Google Scholar 

  87. Alper AT, Akyol A, Hasdemir H et al (2008) Glue (toluene) abuse: increased QT dispersion and relation with unexplained syncope. Inhal Toxicol 20:37–41

    CAS  PubMed  Google Scholar 

  88. Ueda H, Hayashi T, Tsumura K et al (2007) QT dispersion and prognosis after coronary stent placement in acute myocardial infarction. Clin Cardiol 30:229–233

    PubMed  Google Scholar 

  89. Lin YL, Hsiao CL, Wu YC, Kung MF (2011) Electrophysiologic, pharmacokinetic, and pharmacodynamic values indicating a higher risk of torsades de pointes. J Clin Pharmacol 51:819–829

    CAS  PubMed  Google Scholar 

  90. Himmel HM (2008) Mechanisms involved in cardiac sensitization by volatile anesthetics: general applicability to halogenated hydrocarbons? Crit Rev Toxicol 38:773–803

    CAS  PubMed  Google Scholar 

  91. Cruz SL, Orta-Salazar G, Gauthereau MY, Millan-Perez Pena L, Salinas-Stefanon EM (2003) Inhibition of cardiac sodium currents by toluene exposure. Br J Pharmacol 140:653–660

    CAS  PubMed  Google Scholar 

  92. El-Menyar AA, El-Tawil M, Al Suwaidi J (2005) A teenager with angiographically normal epicardial coronary arteries and acute myocardial infarction after butane inhalation. Eur J Emerg Med 12:137–141

    PubMed  Google Scholar 

  93. Samson R, Kado H, Chapman D (2012) Huffing-induced cardiomyopathy: a case report. Cardiovasc Toxicol 12:90–92

    PubMed  Google Scholar 

  94. Lisowska A, Skibinska E, Musial WJ (2004) Severe heart failure due to toxic cardiomyopathy in a young patient—a case report. Kardiologia polska 60:372–373

    PubMed  Google Scholar 

  95. Vural M, Ogel K (2006) Dilated cardiomyopathy associated with toluene abuse. Cardiology 105:158–161

    CAS  PubMed  Google Scholar 

  96. Steffee CH, Davis GJ, Nicol KK (1996) A whiff of death: fatal volatile solvent inhalation abuse. Southern Med J 89:879–884

    CAS  PubMed  Google Scholar 

  97. McLeod AA, Marjot R, Monaghan MJ, Hugh-Jones P, Jackson G (1987) Chronic cardiac toxicity after inhalation of 1,1,1-trichloroethane. Br Med J (Clin Res Ed) 294:727–729

    CAS  Google Scholar 

  98. Pfeiffer H, Al Khaddam M, Brinkmann B, Kohler H, Beike J (2006) Sudden death after isobutane sniffing: a report of two forensic cases. Int J Legal Med 120:168–173

    CAS  PubMed  Google Scholar 

  99. Phatak DR, Walterscheid J (2012) Huffing air conditioner fluid: a cool way to die? The Am J Forensic Med Pathol 33:64–67

    Google Scholar 

  100. Heyer EJ, Simpson DM, Bodis-Wollner I, Diamond SP (1986) Nitrous oxide: clinical and electrophysiologic investigation of neurologic complications. Neurology 36:1618–1622

    CAS  PubMed  Google Scholar 

  101. Layzer RB (1978) Myeloneuropathy after prolonged exposure to nitrous oxide. Lancet 2:1227–1230

    CAS  PubMed  Google Scholar 

  102. Shimizu T, Nishimura Y, Fujishima Y, Miyajima H, Honda N (1989) Subacute myeloneuropathy after abuse of nitrous oxide: an electron microscopic study on the peripheral nerve. Clinical Neurol 29:1129–1135

    CAS  Google Scholar 

  103. Blanco G, Peters HA (1983) Myeloneuropathy and macrocytosis associated with nitrous oxide abuse. Arch Neurol 40:416–418

    CAS  PubMed  Google Scholar 

  104. Drummond JT, Matthews RG (1994) Nitrous oxide inactivation of cobalamin-dependent methionine synthase from Escherichia coli: characterization of the damage to the enzyme and prosthetic group. Biochemistry 33:3742–3750

    CAS  PubMed  Google Scholar 

  105. Ghobrial GM, Dalyai R, Flanders AE, Harrop J (2012) Nitrous oxide myelopathy posing as spinal cord injury. J Neurosurg Spine 16:489–491

    PubMed  Google Scholar 

  106. Butzkueven H, King JO (2000) Nitrous oxide myelopathy in an abuser of whipped cream bulbs. J Clin Neurosci 7:73–75

    CAS  PubMed  Google Scholar 

  107. Krajewski W, Kucharska M, Pilacik B et al (2007) Impaired vitamin B12 metabolic status in healthcare workers occupationally exposed to nitrous oxide. Br J Anaesth 99:812–818

    CAS  PubMed  Google Scholar 

  108. Lin RJ, Chen HF, Chang YC, Su JJ (2011) Subacute combined degeneration caused by nitrous oxide intoxication: case reports. Acta Neurologica Taiwanica 20:129–137

    PubMed  Google Scholar 

  109. Senol MG, Sonmez G, Ozdag F, Saracoglu M (2008) Reversible myelopathy with vitamin B12 deficiency. Singap Med J 49:e330–e332

    CAS  Google Scholar 

  110. Srikanth SG, Jayakumar PN, Vasudev MK, Taly AB, Chandrashekar HS MRI in subacute combined degeneration of spinal cord: a case report and review of literature. Neurology India 50:310–2

  111. Kuwabara S, Kai MR, Nagase H, Hattori T (1999) n-Hexane neuropathy caused by addictive inhalation: clinical and electrophysiological features. Eur Neurol 41:163–167

    CAS  PubMed  Google Scholar 

  112. Smith AG, Albers JW (1997) n-Hexane neuropathy due to rubber cement sniffing. Muscle Nerve 20:1445–1450

    CAS  PubMed  Google Scholar 

  113. Hall DM, Ramsey J, Schwartz MS, Dookun D (1986) Neuropathy in a petrol sniffer. Arch Dis Child 61:900–901

    CAS  PubMed  Google Scholar 

  114. Tenenbein M, deGroot W, Rajani KR (1984) Peripheral neuropathy following intentional inhalation of naphtha fumes. Can Med Assoc J 131:1077–1079

    CAS  PubMed Central  PubMed  Google Scholar 

  115. Altenkirch H, Mager J, Stoltenburg G, Helmbrecht J (1997) Toxic polyneuropathies after sniffing a glue thinner. J Neurol 214:137–152

    Google Scholar 

  116. Korobkin R, Asbury AK, Sumner AJ, Nielsen SL (1975) Glue-sniffing neuropathy. Arch Neurol 32:158–162

    CAS  PubMed  Google Scholar 

  117. Chang AP, England JD, Garcia CA, Sumner AJ (1998) Focal conduction block in n-hexane polyneuropathy. Muscle Nerve 21:964–969

    CAS  PubMed  Google Scholar 

  118. Huang CC (2008) Polyneuropathy induced by n-hexane intoxication in Taiwan. Acta Neurologica Taiwan 17:3–10

    Google Scholar 

  119. Weintraub E, Gandhi D, Robinson C (2000) Medical complications due to mothball abuse. South MedJ 93:427–429

    CAS  Google Scholar 

  120. Szlatenyi CS, Wang RY (1996) Encephalopathy and cranial nerve palsies caused by intentional trichloroethylene inhalation. Am J Emerg Med 14:464–466

    CAS  PubMed  Google Scholar 

  121. Garrel S, Barret L (1986) Somatosensory evoked potentials of the trigeminal nerve in chronic trichloroethylene poisoning. Revue D”electroencephalographie Et De Neurophysiologie Clinique 16:133–139

    CAS  Google Scholar 

  122. Annau Z (1981) The neurobehavioral toxicity of trichloroethylene. Neurobehav Toxicol Teratol 3:417–424

    CAS  PubMed  Google Scholar 

  123. Ehyai A, Freemon FR (1983) Progressive optic neuropathy and sensorineural hearing loss due to chronic glue sniffing. J Neurol Neurosurg Psychiatry 46:349–351

    CAS  PubMed  Google Scholar 

  124. Williams DM (1988) Hearing loss in a glue sniffer. J Otolaryngol 17:321–324

    CAS  PubMed  Google Scholar 

  125. Buker HS, Demir E, Yuncu Z, Gulen F, Midyat L, Tanac R (2011) Effects of volatile substance abuse on the respiratory system in adolescents. Multidisciplinary Respiratory Medicine 6:161–168

    PubMed Central  PubMed  Google Scholar 

  126. Flanagan RJ, Ives RJ (1994)Volatile Substance Abuse, United Nations Office on Drugs and Crime. Retrieved on January 28, 2013 from http://www.unodc.org/unodc/en/data-and-analysis/bulletin/bulletin_1994-01-01_2_page007.html.

  127. Cayir D, Demirel K, Korkmaz M, Koca G (2011) Evaluation of lung epithelial permeability in the volatile substance abuse using Tc-99m DTPA aerosol scintigraphy. Ann Nucl Med 25:554–559

    PubMed  Google Scholar 

  128. Sundram FX (1995) Clinical studies of alveolar-capillary permeability using technetium-99m DTPA aerosol. Ann Nucl Med 9:171–178

    CAS  PubMed  Google Scholar 

  129. Burkhart KK, Britt A, Petrini G, O”Donnell S, Donovan JW (1996) Pulmonary toxicity following exposure to an aerosolized leather protector. J Toxicol Clin Toxicol 34:21–24

    CAS  PubMed  Google Scholar 

  130. Shah MK (2002) Outcomes in patients with Goodpasture’s syndrome and hydrocarbon exposure. Ren Fail 24:545–555

    CAS  PubMed  Google Scholar 

  131. Schloneger M, Stull A, Singer JI. Inhalant abuse: a case of hemoptysis associated with halogenated hydrocarbons abuse. Pediatr Emerg Care 25:754–7

  132. Kurniali PC, Henry L, Kurl R, Meharg JV (2012) Inhalant abuse of computer cleaner manifested as angioedema. Am J Emerg Med 30(265):e3–e5

    PubMed  Google Scholar 

  133. Kuspis DA, Krenzelok EP (1999) Oral frostbite injury from intentional abuse of a fluorinated hydrocarbon. J Toxicol Clin Toxicol 37:873–875

    CAS  PubMed  Google Scholar 

  134. Albright JT, Lebovitz BL, Lipson R, Luft J (1999) Upper aerodigestive tract frostbite complicating volatile substance abuse. Int J Pediatr Otorhinolaryngol 49:63–67

    CAS  PubMed  Google Scholar 

  135. Kurbat RS, Pollack CV Jr (1998) Facial injury and airway threat from inhalant abuse: a case report. J Emerg Med 16:167–169

    CAS  PubMed  Google Scholar 

  136. Elliott DC (1991) Frostbite of the mouth: a case report. Military Medicine 156:18–19

    CAS  PubMed  Google Scholar 

  137. Weber LW, Boll M, Stampfl A (2003) Hepatotoxicity and mechanism of action of haloalkanes: carbon tetrachloride as a toxicological model. Crit Rev Toxicol 33:105–136

    CAS  PubMed  Google Scholar 

  138. McIntyre AS, Long RG (1992) Fatal fulminant hepatic failure in a “solvent abuser”. Postgrad Med J 68:29–30

    CAS  PubMed  Google Scholar 

  139. Beisland HO, Wannag SA (1970) Trichloroethylene sniffing. Acute liver and kidney damage. Tidsskrift for den Norske laegeforening 90:285–288

    CAS  PubMed  Google Scholar 

  140. Clearfield HR (1970) Hepatorenal toxicity from sniffing spot-remover (trichloroethylene). Report of 2 cases. Am J Dig Dis 15:851–856

    CAS  PubMed  Google Scholar 

  141. Takaki A, Suzuki H, Iwasaki Y et al (2008) A 27-year-old man who died of acute liver failure probably due to trichloroethylene abuse. J Gastroenterol 43:239–242

    PubMed  Google Scholar 

  142. Ramdhan DH, Kamijima M, Yamada N et al (2008) Molecular mechanism of trichloroethylene-induced hepatotoxicity mediated by CYP2E1. Toxicol Appl Pharmacol 231:300–307

    CAS  PubMed  Google Scholar 

  143. Batlle DC, Sabatini S, Kurtzman NA (1988) On the mechanism of toluene-induced renal tubular acidosis. Nephron 49:210–218

    CAS  PubMed  Google Scholar 

  144. Dickson RP, Luks AM (2009) Toluene toxicity as a cause of elevated anion gap metabolic acidosis. Respir Care 54:1115–1117

    PubMed  Google Scholar 

  145. Erramouspe J, Galvez R, Fischel DR (1996) Newborn renal tubular acidosis associated with prenatal maternal toluene sniffing. J Psychoactive Drugs 28:201–204

    CAS  PubMed  Google Scholar 

  146. Lock EA, Reed CJ (2006) Trichloroethylene: mechanisms of renal toxicity and renal cancer and relevance to risk assessment. Toxicol Sci 91:313–331

    CAS  PubMed  Google Scholar 

  147. Dubosq F, Linke C, Cardot V, Meria P, Desgrandchamps F, Teillac P (2005) Renal cell carcinoma and trichloroethylene. Progres en urologie 15:525–528

    PubMed  Google Scholar 

  148. Wilkerson RG (2010) Getting the blues at a rock concert: a case of severe methaemoglobinaemia. Emerg Med Australas 22:466–469

    PubMed  Google Scholar 

  149. Modarai B, Kapadia YK, Kerins M, Terris J (2002) Methylene blue: a treatment for severe methaemoglobinaemia secondary to misuse of amyl nitrite. Emerg Med J 19:270–271

    CAS  PubMed  Google Scholar 

  150. Edwards RJ, Ujma J (1995) Extreme methaemoglobinaemia secondary to recreational use of amyl nitrite. J Accid Emerg Med 12:138–142

    CAS  PubMed Central  PubMed  Google Scholar 

  151. Stambach T, Haire K, Soni N, Booth J (1997) Saturday night blue—a case of near fatal poisoning from the abuse of amyl nitrite. J Accid Emerg Med 14:339–340

    CAS  PubMed Central  PubMed  Google Scholar 

  152. Praharaj SK, Kongasseri S (2012) Naphthalene Addict Subst Abus 33:189–190

    Google Scholar 

  153. Valaes T, Doxiadis SA, Fessas P (1963) Acute hemolysis due to naphthalene inhalation. J Pediatr 63:904–915

    CAS  PubMed  Google Scholar 

  154. Santucci K, Shah B (2000) Association of naphthalene with acute hemolytic anemia. Acad Emerg Med 7:42–47

    CAS  PubMed  Google Scholar 

  155. Athanasiou M, Tsantali C, Trachana M, Hatziioannides C (1997) Hemolytic anemia in a female newborn infant whose mother inhaled naphthalene before delivery. J Pediatr 130:680–681

    CAS  PubMed  Google Scholar 

  156. Raphael M, Nadiras P, Flacke-Vordos N (2002) Acute methylene chloride intoxication—a case report on domestic poisoning. Eur J Emerg Med 9:57–59

    CAS  PubMed  Google Scholar 

  157. Horowitz BZ (1986) Carboxyhemoglobinemia caused by inhalation of methylene chloride. Am J Emerg Med 4:48–51

    CAS  PubMed  Google Scholar 

  158. Rioux JP, Myers RAM (1998) Methylene chloride poisoning: a paradigmatic review. J Emerg Med 6:227–238

    Google Scholar 

  159. Peckham T, Kopstein M, Klein J, Dahlgren J (2012), Benzene-contaminated toluene and acute myeloid leukemia: a case series and review of literature. Toxicology and industrial health. Epub ahead of print Jun 27, 2012

  160. Lasala BJ, Zaenglein AL (2012) Cutaneous and mucosal blistering secondary to "Huffing". Pediatr Dermatol. Epub September 4, 2012

  161. Janezic TF (1997) Burns following petrol sniffing. Burns 23:78–80

    CAS  PubMed  Google Scholar 

  162. Ho WS, To EW, Chan ES, King WW (1998) Burn injuries during paint thinner sniffing. Burns 24:757–759

    CAS  PubMed  Google Scholar 

  163. Levine B (2003) Principles of forensic toxicology, 2nd edn. AACC, Washington, DC

    Google Scholar 

  164. Wang RS, Nakajima T, Honma T (1999) Trichloroethylene inhibits aldehyde dehydrogenase only for aliphatic aldehydes of short chains in rats. Toxicology 132:9–18

    CAS  PubMed  Google Scholar 

  165. Bowen SE (2011) Two serious and challenging medical complications associated with volatile substance misuse: sudden sniffing death and fetal solvent syndrome. Subst Use Misuse 46(Suppl 1):68–72

    PubMed  Google Scholar 

  166. Hersh JH, Podruch PE, Rogers G, Weisskopf B (1985) Toluene embryopathy. J Pediatr 106:922–927

    CAS  PubMed  Google Scholar 

  167. Hersh JH (1989) Toluene embryopathy: two new cases. J Med Genet 26:333–337

    CAS  PubMed  Google Scholar 

  168. Arai H, Yamada M, Miyake S et al (1997) Two cases of toluene embryopathy with severe motor and intellectual disabilities syndrome. Brain Dev 29:361–366

    CAS  Google Scholar 

  169. Pearson MA, Hoyme HE, Seaver LH, Rimsza ME (1994) Toluene embryopathy: delineation of the phenotype and comparison with fetal alcohol syndrome. Pediatrics 93:211–215

    CAS  PubMed  Google Scholar 

  170. Ozmen S, Seckin N, Turhan NO, Dilmen G, Dilmen U (1995) Fetal methemoglobinemia: a cause of nonimmune hydrops fetalis. Am J Obstet Gynecol 173:232–233

    CAS  PubMed  Google Scholar 

  171. Dodd J (2001) Petrol sniffing in a pregnant Aboriginal population: a review of maternal and neonatal outcomes. Aust N Z J Obstet Gynaecol 41:420–423

    CAS  PubMed  Google Scholar 

  172. Tenenbein M, Casiro OG, Seshia MM, Debooy VD. Neonatal withdrawal from maternal volatile substance abuse. Archives of disease in childhood Fetal and neonatal edition. 74, F204-7

  173. Nee PA, Llewellyn T, Pritty PE (1990) Successful out-of-hospital defibrillation for ventricular fibrillation complicating solvent abuse. Arch Emerg Med 7:220–223

    CAS  PubMed Central  PubMed  Google Scholar 

  174. Senthilkumaran S, Meenakshisundaram R, Michaels AD, Balamurgan N, Thirumalaikolundusubramanian P (2012) Ventricular fibrillation after exposure to air freshener-death just a breath away. J Electrocardiol 45:164–166

    PubMed  Google Scholar 

  175. Tang W, Weil MH, Sun S, Noc M, Yang L, Gazmuri RJ (1995) Epinephrine increases the severity of postresuscitation myocardial dysfunction. Circulation 92:3089–3093

    CAS  PubMed  Google Scholar 

  176. de Oliveira FC, Feitosa-Filho GS, Ritt LE (2012) Use of beta-blockers for the treatment of cardiac arrest due to ventricular fibrillation/pulseless ventricular tachycardia: a systematic review. Resuscitation 83:674–683

    PubMed  Google Scholar 

  177. Nademanee K, Taylor R, Bailey WE, Rieders DE, Kosar EM (2000) Treating electrical storm : sympathetic blockade versus advanced cardiac life support-guided therapy. Circulation 102:742–747

    CAS  PubMed  Google Scholar 

  178. Miwa Y, Ikeda T, Mera H et al (2010) Effects of landiolol, an ultra-short-acting beta1-selective blocker, on electrical storm refractory to class III antiarrhythmic drugs. Circ J 74:856–863

    CAS  PubMed  Google Scholar 

  179. Wiest DB, Haney JS (2012) Clinical pharmacokinetics and therapeutic efficacy of esmolol. Clin Pharmacokinet 51:347–356

    CAS  PubMed  Google Scholar 

  180. Burns CB, Currie B The efficacy of chelation therapy and factors influencing mortality in lead intoxicated petrol sniffers. Aust N Z J Med. 25:197–203

  181. Skacel PO, Chanarin I, Hewlett A, Nunn JF (1982) Failure to correct nitrous oxide toxicity with folinic acid. Anesthesiology 57:557–558

    CAS  PubMed  Google Scholar 

  182. Amos RJ, Amess JA, Nancekievill DG, Rees GM (1984) Prevention of nitrous oxide-induced megaloblastic changes in bone marrow using folinic acid. Br J Anaesth 56:103–107

    CAS  PubMed  Google Scholar 

  183. Nunn JF, Chanarin I, Tanner AG, Owen ER (1986) Megaloblastic bone marrow changes after repeated nitrous oxide anaesthesia. Reversal with folinic acid. Br J Anaesth 58:1469–1470

    CAS  PubMed  Google Scholar 

  184. Lee JH, Sung CH, Moon SH, Kim SN, Chung WH (1993) Folinic acid protection against hematopoietic depression induced by nitrous oxide in rats. Anesth Analg 77:356–361

    CAS  PubMed  Google Scholar 

  185. Barceloux DG, Bond GR, Krenzelok EP, Cooper H, Vale JA (2002) American Academy of Clinical Toxicology practice guidelines on the treatment of methanol poisoning. J Toxicol Clin Toxicol 40:415–446

    CAS  PubMed  Google Scholar 

  186. Rioux JP, Myers RA (1988) Methylene chloride poisoning: a paradigmatic review. J Emerg Med 6:227–238

    CAS  PubMed  Google Scholar 

  187. Rioux JP, Myers RA (1989) Hyperbaric oxygen for methylene chloride poisoning: report on two cases. Ann Emerg Med 18:691–695

    CAS  PubMed  Google Scholar 

  188. Rudge FW (1990) Treatment of methylene chloride induced carbon monoxide poisoning with hyperbaric oxygenation. Military Med 155:570–572

    CAS  Google Scholar 

  189. Galicia-Moreno M, Rodriguez-Rivera A, Reyes-Gordillo K et al (2009) N-acetylcysteine prevents carbon tetrachloride-induced liver cirrhosis: role of liver transforming growth factor-beta and oxidative stress. Eur J Gastroenterol Hepatol 21:908–914

    CAS  PubMed  Google Scholar 

  190. Gerkin RD Jr, LoVecchio F (1998) Rapid reversal of life-threatening toluene-induced hypokalemia with hemodialysis. J Emergency Med 16:723–725

    Google Scholar 

  191. MacLean S, Cameron J, Harney A, Lee NK (2012) Psychosocial therapeutic interventions for volatile substance use: a systematic review. Addiction 107:278–288

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Emergency Medicine, School of Medicine, University of California, Davis, 4150 V Street, PSSB 2100, Sacramento, CA, 95817, USA

    Jonathan B. Ford, Mark E. Sutter, Kelly P. Owen & Timothy E. Albertson

  2. Veterans Administration Northern California Healthcare System, 10535 Hospital Way, Mather, CA, 95655, USA

    Jonathan B. Ford & Timothy E. Albertson

  3. Department of Internal Medicine, School of Medicine, University of California, Davis, 4150 V Street, PSSB 3100, Sacramento, CA, 95817, USA

    Timothy E. Albertson

Authors
  1. Jonathan B. Ford
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mark E. Sutter
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kelly P. Owen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Timothy E. Albertson
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jonathan B. Ford.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ford, J.B., Sutter, M.E., Owen, K.P. et al. Volatile Substance Misuse: An Updated Review of Toxicity and Treatment. Clinic Rev Allerg Immunol 46, 19–33 (2014). https://doi.org/10.1007/s12016-013-8371-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12016-013-8371-1

Keywords

Search

Navigation